Harmacy.net
Buy Online and Save
  Start saving money on
your Prescriptions with
       cheap generic drugs...
  @ Buy-Cheap-Generic-Harmacy.net-Online.com
 

Drug Information

ZIOPTAN
Tafluprost 0.0015%; oph soln; preservative-free.

KORLYM
Mifepristone 300mg; tabs.

High Doses of Oxymorphone Extended-Release Generally Well Tolerated
At the American Pain Society's 31st Annual Scientific Meeting, study investigators presented data indicating that high dosages of oxymorphone extended-release (ER) appear to be generally well tolerated in patients with chronic noncancer pain.

ARCAPTA NEOHALER
Indacaterol 75mcg; inhalation pwd hard capsules for use with Neohaler device.

Flurbiprofen Lozenge Provides Lasting Relief of Pharyngeal Pain
Flurbiprofen 8.75mg lozenge provides lasting relief of pharyngeal pain, noted Dr. Bernard Schachtel, from New York University, New York, NY, at the American Pain Society's 31st Annual Scientific Meeting.

Research Increasingly Points to Migraine as Neurological (vs. Vascular) Disorder
Recent research has resulted in a very rich pipeline of new agents to treat migraine, said David Dodick, MD, in presenting the Global Year Against Pain Lecture at the American Pain Society's 31st Annual Scientific Meeting.

QNASL
Beclomethasone dipropionate 80mcg/actuation; non-aqueous nasal spray soln.

Physicians Challenged with Tapering Patients on High Dose Opioids for Chronic Noncancer Pain
Legislation recently enacted in the State of Washington to moderate opioid dosing in light of a 240% increase in deaths between 2001 and 2009 is placing physicians in the position of negotiating with patients with chronic noncancer pain to taper doses, a panel of physicians noted during the American Pain Society's 31st Annual Scientific Meeting.

JENTADUETO
Linagliptin, metformin HCl; 2.5mg/500mg, 2.5mg/850mg, 2.5mg/1000mg; tablets.

Nano-formulated Naproxen Provides Faster Pain Relief than Traditional Naproxen
Using nano-formulated, lower-dose NSAIDs may provide clinical benefit for relieving mild to moderate acute pain, reported Garen Manvelian, MD, with Iroko Pharmaceuticals, Philadelphia, PA, at the American Pain Society's 31st Annual Scientific Meeting.